Reply to the letter to the editor regarding the study “The effectiveness of gabapentin and gabapentin/montelukast combination compared with dextromethorphan in the improvement of COVID‐19‐related cough: A randomized, controlled clinical trial”

Atousa Hakamifard; Rasool Soltani

doi:10.1111/crj.13619

journal article Open Access Apr 26, 2023

Reply to the letter to the editor regarding the study “The effectiveness of gabapentin and gabapentin/montelukast combination compared with dextromethorphan in the improvement of COVID‐19‐related cough: A randomized, controlled clinical trial”

Atousa Hakamifard

Rasool Soltani

The Clinical Respiratory Journal Vol. 17 No. 6 pp. 603-604 · Wiley

View at Publisher Save 10.1111/crj.13619

Topics

No keywords indexed for this article. Browse by subject →

References

1

[1]

10.1111/crj.13529

Metrics

1

Citations

1

References

Details

Published: Apr 26, 2023
Vol/Issue: 17(6)
Pages: 603-604
License: View

Authors

A

Atousa Hakamifard

Department of Infectious Diseases, School of Medicine Isfahan University of Medical Sciences Isfahan Iran; Infectious Diseases and Tropical Medicine Research Center Shahid Beheshti University of Medical Sciences Tehran Iran

R

Rasool Soltani

Infectious Diseases and Tropical Medicine Research Center Isfahan University of Medical Sciences Isfahan Iran; Department of Clinical Pharmacy and Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences Isfahan University of Medical Sciences Isfahan Iran

Cite This Article

Atousa Hakamifard, Rasool Soltani (2023). Reply to the letter to the editor regarding the study “The effectiveness of gabapentin and gabapentin/montelukast combination compared with dextromethorphan in the improvement of COVID‐19‐related cough: A randomized, controlled clinical trial”. The Clinical Respiratory Journal, 17(6), 603-604. https://doi.org/10.1111/crj.13619

Reply to the letter to the editor regarding the study “The effectiveness of gabapentin and gabapentin/montelukast combination compared with dextromethorphan in the improvement of COVID‐19‐related cough: A randomized, controlled clinical trial”

You May Also Like